Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Brintellix Forced To Change Name Due to Similarity to Brilinta May 9, 2016 Russell Maas Add Your Comments Amid continuing problems with medication mixups involving the antidepressant Brintellix and blood thinner Brilinta, federal regulators indicate that the makers of Brintellix will change the name of their product to Trintellix. In a drug safety communication issued last week, the FDA indicates that it is aware of at least 50 reports of problems with prescribing or dispensing the drugs due to name confusion, which could pose a serious health risk for consumers who receive a blood thinner instead of an antidepressant. The agency previously attempted to address the problem by issuing a warning for doctors, pharmacies and other healthcare providers about the risk of medication errors with Brintellix and Brilinta in July 2015. However, problems have continued to be reported, although the agency indicates that it is not aware of any adverse health consequences caused by ingesting the wrong medication. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Brintellix is an antidepressant drug used to treat adult patients with major depressive disorders (MDD). The drug is part of a class of antidepressants called serotonin reuptake inhibitors (SSRIs), which are designed to re-balance chemical levels in the brain to decrease depression. The medication is manufactured by Takeda Pharmaceuticals and the tablets are tea-shaped and have a “TL” on one side and a number representing he strength on the other side. The pills vary in color depending on the strength, however some are produced in a yellow color similar to Brilinta. Brilinta is an anti-platelet, anti-blood clotting medication that lowers the risk of having another heart attack or dying from heart problems following a heart attack or severe chest pain. The drug keeps the platelets from sticking together, preventing blood clots from forming. The tablets are round and yellow, with a 90 above a T stamped on one side. The drug is manufactured by AstraZeneca PLC and has substantially grown in popularity throughout the medical field since it was approved by the FDA in July 2011. Increasing prescribing and dispensing errors are occurring due to name confusion and similarity of pill appearance, since both can appear as small yellow tablets. Problems have also reportedly stemmeing from medical coding errors, which records the first three letters of the medication before producing the suggested medication, often leading to further confusion between Brilinta and Brintellix. According to the FDA statement, outcomes from a prescribing error could be fatal. Patients needing prescriptions for Brilinta that wrongfully receive the antidepressant medication Brintellix in error can suffer severe side effects including increased risk of heart attacks, strokes, and the formation of blood clots in arteries and veins throughout the body. Patients who are wrongfully prescribed the blood thinner Brilinta are susceptible to serious adverse health consequences also due to failure to treat their MDD, which left untreated could lead to severe depression, insomnia, mood swings and suicidal thoughts among many other side effects. Patients also under the improper use of a blood thinner could be more susceptible to severe bleeding events requiring immediate medical intervention. The new brand name Trintellix is set to begin being displayed on the prescription bottles starting in June 2016, and healthcare professionals are being informed that no other label, packaging, or pill appearance changes are being made. Healthcare professionals, pharmacists and consumers should all carefully check to make sure they are dispensing or receiving the correct medicine. Takeda Pharmaceuticals will be providing the generic name of Brintellix/Trintellix on the packaging to help avoid confusion, which is Vortioxetine. The name confusion problems come amid increasing concerns about the risks that may be linked to side effects of Brilinta, after a study published last year suggested that users may be less likely to suffer a second heart attack, but face an increased risk of dangerous bleeding events. In 2013, the U.S. Department of Justice launched an investigation into previous clinical trials on Brilinta, after a report published in the International Journal of Cardiology suggested that AstraZeneca may have manipulated data during an 18,000-patient clinical trial to make the drug appear safe when data suggested otherwise. The report detailed that there were a number of irregularities during the clinical trial and suggested that reports of heart attacks linked to Brilinta may have been under-reported. Tags: Brilinta, Brintellix, Medication Error, Trintellix More Lawsuit Stories Motorcycle Deaths Nearly 28 Times Higher Than Car Occupant Fatalities: NHTSA May 19, 2025 MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 May 16, 2025 Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study May 16, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025) BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 5 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 5 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)